Compare WHK & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WHK | SGP |
|---|---|---|
| Founded | N/A | 2019 |
| Country | | United States |
| Employees | N/A | 65 |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 704.3M | 650.9M |
| IPO Year | 2026 | N/A |
| Metric | WHK | SGP |
|---|---|---|
| Price | $25.92 | $22.52 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $45.00 |
| AVG Volume (30 Days) | ★ 218.2K | 155.2K |
| Earning Date | N/A | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $25.65 | $17.06 |
| 52 Week High | $28.60 | $30.56 |
| Indicator | WHK | SGP |
|---|---|---|
| Relative Strength Index (RSI) | 35.51 | 61.57 |
| Support Level | N/A | $20.95 |
| Resistance Level | $28.60 | $22.80 |
| Average True Range (ATR) | 1.11 | 1.74 |
| MACD | -0.16 | 0.31 |
| Stochastic Oscillator | 8.63 | 93.20 |
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.